The effects of pentoxifylline on the survival of human glioma cells with continuous and intermittent stereotactic radiosurgery irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 2, 2002, Pages 542-550

  Eley, Kerry W ^a   Benedict, Stanley H ^a   Chung, T D K ^a   Kavanagh, Brian D ^c   Broaddus, William C ^b   Schmidt Ullrich, R K A ^a   Lin, Peck Sun ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Cell cycle; Pentoxifylline; Spheroids; Stereotactic radiosurgery; T98G

Indexed keywords

BIOASSAY; CELL CULTURE; DNA; ENZYMES; IRRADIATION; OXYGEN; RADIOTHERAPY; SURGERY;

RADIOSURGERY;

ONCOLOGY;

DNA; OXYGEN; PENTOXIFYLLINE;

ARTICLE; CELL CYCLE; CELL LINE; CELL SURVIVAL; CELLULAR PARAMETERS; CLONOGENIC ASSAY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FLOW CYTOMETRY; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRADIATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIOSENSITIZATION; RADIOSURGERY; STEREOTAXIC SURGERY; TIME; TUMOR CELL;

CELL SURVIVAL; DNA REPAIR; FLOW CYTOMETRY; G2 PHASE; GLIOMA; HUMANS; PENTOXIFYLLINE; RADIATION DOSAGE; RADIATION-PROTECTIVE AGENTS; RADIATION-SENSITIZING AGENTS; RADIOBIOLOGY; RADIOSURGERY; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 0036803141     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02983-8     Document Type: Article

References (26)

1. Lutz W., Winston K.R., Maleki N. A system for stereotactic radiosurgery with a linear accelerator. Int J Radiat Oncol Biol Phys. 14:(2):1988;373-381.
2. Benedict S.H., Lin P.S., Zwicker R.D., Huang D.T., Schmidt-Ullrich R.K.A. The biological effectiveness of intermittent irradiation as a function of overall treatment time Development of correction factors for linac-based stereotactic radiotherapy . Int J Radiat Oncol Biol Phys. 37:(4):1997;765-769.
3. Benedict S.H., Lin P.S., Zwicker R.D., Kwandelwal S., Broaddus W.C., Schmidt-Ullrich R.K.A. Stereotactic radiosurgery The relative biological effect of continuous vs. intermittent radiation exposures . Radiat Oncol Invest. 2:1994/1995;219-223.
4. Theron T., Binder A., Verheye-Dua F., Bohm L. The role of G2-block abrogation, DNA double-strand break repair and apoptosis in the radiosensitization of melanoma and squamous cell carcinoma cell lines by pentoxifylline. Int J Radiat Biol. 76:(9):2000;1197-1208.
5. Russell K.J., Wiens L.W., Demers G.W., et al. Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines. Int J Radiat Oncol Biol Phys. 36:(5):1996;1099-1106.
6. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
7. Binder A.B., Serafin A.M., Bohm L.J. Abrogation of G(2)/M-phase block enhances the cytotoxicity of daunorubicin, melphalan and cisplatin in TP53 mutant human tumor cells. Radiat Res. 154:(6):2000;640-649.
8. Theron T., Bohm L. Influence of the G2 cell cycle block abrogator pentoxifylline on the expression and subcellular location of cyclin B1 and p34cdc2 in HeLa cervical carcinoma cells. Cell Prolif. 33:(1):2000;39-50.
9. Bohm L., Theron T., Binder A. Influence of pentoxifylline, A-802710, propentofylline and A-802715 (Hoechst) on the expression of cell cycle blocks and S-phase content after irradiation damage. Biochim Biophys Acta. 1499:(1-2):2000;1-10.
10. Li Y.X., Weber-Johnson K., Sun L.Q., Paschoud N., Mirimanoff R.O., Coucke P.A. Effect of pentoxifylline on radiation-induced G2-phase delay and radiosensitivity of human colon and cervical cancer cells. Radiat Res. 149:(4):1998;338-342.
11. Sperduto P.W., Song C.W., Levitt S.H. The in vitro radiosensitization of human glioblastoma with pentoxifylline. Am J Clin Oncol. 16:(5):1993;407-411.
12. Durand R.E. Cure, regression and cell survival A comparison of common radiobiological endpoints using an in vitro tumor model . Br J Radiol. 48:1975;556-571.
13. Gaze M.N., Mairs R.J., Boyack S.M., Wheldon T.E., Barrett A. 131-Imetaiodobenzyl granidine therapy in neuroblastoma spheroids of different sizes. Br J Cancer. 66:1992;1048-1052.
14. Yamagishi N., Miyakoshi J., Ohtsu S., Day R.S. 3rd, Takebe H. Modification of the radiosensitivity of human cells to which simian virus 40 T-antigen was transfected. J Radiat Res (Tokyo). 36:(4):1995;239-247.
15. Ormerod M.G. Flow cytometry A practical approach . 2nd ed. 1994;Oxford University Press Inc, New York.
16. Kim S.H., Khil M.S., Ryu S., Kim J.H. Enhancement of radiation response on human carcinoma cells in culture by pentoxifylline. Int J Radiat Oncol Biol Phys. 25:(1):1993;61-65.
17. Vernimmen F., Verheye-Dua F., du Toit H., Bohm L. Effect of pentoxifylline on radiation damage and tumor growth. Strahlenther Onkol. 170:(10):1994;595-601.
18. Lee I., Biaglow J.E., Lee J., Cho M.J. Physiological mechanisms of radiation sensitization by pentoxifylline. Anticancer Res. 20:(6B):2000;4605-4609.
19. Lee I., Levitt S.H., Song C.W. Improved tumour oxygenation and radiosensitization by combination with nicotinamide and pentoxifylline. Int J Radiat Biol. 64:(2):1993;237-244.
20. Kavanagh B.D., Coffey B.E., Needham D., Hochmuth R.M., Dewhirst M.W. The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment. Br J Cancer. 67:(4):1993;734-741.
21. Kruger A., Matulla B., Wolzt M., et al. Short-term oral pentoxifylline use increases choroidal blood flow in patients with age-related macular degeneration. Arch Ophthalmol. 116:(1):1998;27-30.
22. Ciocon J.O., Galindo-Ciocon D., Galindo D.J. A comparison between aspirin and pentoxifylline in relieving claudication due to peripheral vascular disease in the elderly. Angiology. 48:(3):1997;237-240.
23. Korenman S.G., Viosca S.P. Treatment of vasculogenic sexual dysfunction with pentoxifylline. J Am Geriatr Soc. 41:(4):1993;363-366.
24. Brenman S.A. Pentoxifylline as adjunctive therapy in leg ulcer management. J Am Osteopath Assoc. 91:(7):1991;677-686. (Review).
25. Delanian S., Balla-Mekias S., Lefaix J.L. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol. 17:(10):1999;3283-3290.
26. Johnson F.E., Harrison B.R., McKirgan L.W., Raju P.I., Roy T.K., Virgo K.S. A phase II evaluation of pentoxifylline combined with radiation in the treatment of brain metastases. Int J Oncol. 13:(4):1998;801-805.